209 related articles for article (PubMed ID: 10218730)
1. Mibefradil-induced inhibition of proliferation of human peripheral blood mononuclear cells.
Lijnen P; Fagard R; Petrov V
J Cardiovasc Pharmacol; 1999 Apr; 33(4):595-604. PubMed ID: 10218730
[TBL] [Abstract][Full Text] [Related]
2. Proliferation of human peripheral blood mononuclear cells during calcium channel blockade.
Lijnen P; Fagard R; Petrov V
Am J Hypertens; 1998 Dec; 11(12):1461-8. PubMed ID: 9880128
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of proliferation of human peripheral blood mononuclear cells by calcium antagonists. Role of interleukin-2.
Petrov V; Lijnen P
Methods Find Exp Clin Pharmacol; 2000; 22(1):19-23. PubMed ID: 10791290
[TBL] [Abstract][Full Text] [Related]
4. Proliferation of human peripheral blood mononuclear cells during calcium entry blockade. Role of protein kinase C.
Lijnen P; Petrov V
Methods Find Exp Clin Pharmacol; 1999 May; 21(4):253-9. PubMed ID: 10399131
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of calcium channel blockers on human mesangial cell growth: evidence for actions independent of L-type Ca2+ channels.
Orth SR; Nobiling R; Bönisch S; Ritz E
Kidney Int; 1996 Mar; 49(3):868-79. PubMed ID: 8648932
[TBL] [Abstract][Full Text] [Related]
6. Cytosolic calcium and lymphoproliferative response during calcium antagonism in men.
Lijnen P; Fagard R; Petrov V
Eur J Clin Pharmacol; 1999 Feb; 54(12):911-5. PubMed ID: 10192750
[TBL] [Abstract][Full Text] [Related]
7. Mibefradil, A T-type calcium channel antagonist in Y1 cells.
Esneu M; Gallo-Payet N; Payet MD
Endocr Res; 1998; 24(3-4):449-54. PubMed ID: 9888524
[TBL] [Abstract][Full Text] [Related]
8. Changes of cardiac calcium homeostasis in spontaneously hypertensive rats.
Manso AM; Encabo A; Ferrer M; Balfagón G; Salaices M; Marín J
J Auton Pharmacol; 1999 Apr; 19(2):123-30. PubMed ID: 10466946
[TBL] [Abstract][Full Text] [Related]
9. Blockade by NS-7, a neuroprotective compound, of both L-type and P/Q-type Ca2+ channels involving depolarization-stimulated nitric oxide synthase activity in primary neuronal culture.
Oka M; Itoh Y; Ukai Y; Kimura K
J Neurochem; 1999 Mar; 72(3):1315-22. PubMed ID: 10037505
[TBL] [Abstract][Full Text] [Related]
10. Voltage-dependent blockade of diverse types of voltage-gated Ca2+ channels expressed in Xenopus oocytes by the Ca2+ channel antagonist mibefradil (Ro 40-5967).
Bezprozvanny I; Tsien RW
Mol Pharmacol; 1995 Sep; 48(3):540-9. PubMed ID: 7565636
[TBL] [Abstract][Full Text] [Related]
11. Mibefradil (Ro 40-5967) blocks multiple types of voltage-gated calcium channels in cultured rat spinal motoneurones.
Viana F; Van den Bosch L; Missiaen L; Vandenberghe W; Droogmans G; Nilius B; Robberecht W
Cell Calcium; 1997 Oct; 22(4):299-311. PubMed ID: 9481480
[TBL] [Abstract][Full Text] [Related]
12. L, P-/Q- and T-type Ca2+ channels in smooth muscle cells from human umbilical artery.
Salemme S; Rebolledo A; Speroni F; Petruccelli S; Milesi V
Cell Physiol Biochem; 2007; 20(1-4):55-64. PubMed ID: 17595515
[TBL] [Abstract][Full Text] [Related]
13. Ca2+ channel actions of the non-dihydropyridine Ca2+ channel antagonist Ro 40-5967 in vascular muscle cells cultured from dog coronary and saphenous arteries.
Bian K; Hermsmeyer K
Naunyn Schmiedebergs Arch Pharmacol; 1993 Aug; 348(2):191-6. PubMed ID: 7694155
[TBL] [Abstract][Full Text] [Related]
14. Structure and functional characterization of a novel human low-voltage activated calcium channel.
Williams ME; Washburn MS; Hans M; Urrutia A; Brust PF; Prodanovich P; Harpold MM; Stauderman KA
J Neurochem; 1999 Feb; 72(2):791-9. PubMed ID: 9930755
[TBL] [Abstract][Full Text] [Related]
15. Effects of Ca2+ channel blockers on Ca2+ loading induced by metabolic inhibition and hyperkalemia in cardiomyocytes.
Tang T; Duffield R; Ho AK
Eur J Pharmacol; 1998 Nov; 360(2-3):205-11. PubMed ID: 9851587
[TBL] [Abstract][Full Text] [Related]
16. Mibefradil prevents neointima formation after vascular injury in rats. Possible role of the blockade of the T-type voltage-operated calcium channel.
Schmitt R; Clozel JP; Iberg N; Bühler FR
Arterioscler Thromb Vasc Biol; 1995 Aug; 15(8):1161-5. PubMed ID: 7627710
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological dissection of Ca2+ channels in the rat aorta by Ca2+ entry modulators.
Rico I; Alonso MJ; Salaices M; Marín J
Pharmacology; 1990; 40(6):330-42. PubMed ID: 1700444
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of action of the inhibitory effect of nifedipine on the growth of cultured aortic cells from spontaneously hypertensive and normotensive rats.
Hérembert T; Zhu DL; Marche P
Br J Pharmacol; 1995 Apr; 114(8):1703-9. PubMed ID: 7541285
[TBL] [Abstract][Full Text] [Related]
19. Inhibition by mibefradil, a novel calcium channel antagonist, of Ca(2+)- and volume-activated Cl- channels in macrovascular endothelial cells.
Nilius B; Prenen J; Kamouchi M; Viana F; Voets T; Droogmans G
Br J Pharmacol; 1997 Jun; 121(3):547-55. PubMed ID: 9179399
[TBL] [Abstract][Full Text] [Related]
20. Effect of the Ca(2+)-channel agonist Bay K 8644 on the contractile responses in human placental veins.
Barrús MT; Reviriego J; Marín J
J Auton Pharmacol; 1996 Jun; 16(3):161-7. PubMed ID: 8884463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
